Other FDA Approved Peptides
Other Peptides & Hormones in FDA-Approved Medicines
In addition to tirzepatide, several other peptide-based compounds and hormones are active ingredients in FDA-approved prescription medicines in the United States. These include PT-141 (bremelanotide) and Human Chorionic Gonadotropin (HCG).
PT-141 (Bremelanotide) — Vyleesi®
FDA-approved active ingredient: Bremelanotide is the active ingredient in Vyleesi®, an FDA-approved prescription medicine for acquired, generalized hypoactive sexual desire disorder (HSDD) in certain premenopausal women.
PT-141 is studied in research involving melanocortin receptor pathways, central nervous system signalling and sexual response mechanisms.
VIEW FDA VYLEESI INFORMATION →HCG (Human Chorionic Gonadotropin) — Pregnyl® & Novarel®
FDA-approved active ingredient: Human Chorionic Gonadotropin is the active ingredient in FDA-approved prescription medicines including Pregnyl® and Novarel®. These medicines have approved indications involving certain fertility treatments and specific hormonal conditions.
HCG is a glycoprotein hormone studied in reproductive biology, luteinizing hormone receptor activation, steroidogenesis and endocrine signalling research.
VIEW FDA DRUG DATABASE →Important regulatory distinction: FDA approval applies to specific prescription medicines, formulations and medical indications. It does not extend to independently supplied PT-141, HCG or other research materials, even when they are described as containing the same active ingredient. Research products are not established as equivalent in manufacturing quality, purity, biological potency, safety or effectiveness. Peptides Suppliers' research products are not FDA-approved medicines and are not intended for human use.